Figure 1From: Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisEMP levels at different time points in IFN-β1a-treated MS patients. EMP levels are significantly different over time, p < .016 as compared to baseline, by the Friedman nonparametric test. The levels decrease monotonically, and this trend is highly significant, p = 0.003. Error bars are 95% confidence limits of the mean. Note that the horizontal scale is not linear.Back to article page